Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-47627-1, published online 08 August 2019
The original version of this Article contained an error in Affiliation 4, which was incorrectly given as ‘IOV- IRCCS, Padova, Italy’. The correct affiliation is listed below:
Istituto Oncologico Veneto IOV – IRCCS, Padova, Italy
This error has now been corrected in the HTML and PDF versions of the Article, and in the accompanying Supplemental Material.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ruzzo, A., Graziano, F., Galli, F. et al. Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy. Sci Rep 10, 1918 (2020). https://doi.org/10.1038/s41598-020-58486-6
Published:
DOI: https://doi.org/10.1038/s41598-020-58486-6
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
